Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Pulmonary Arterial Hypertension Market Intelligence Report - Global Forecast to 2025

Published by 360iResearch LLP Product code 931020
Published Content info 45 Pages
Delivery time: 1-2 business days
Price
Back to Top
Pulmonary Arterial Hypertension Market Intelligence Report - Global Forecast to 2025
Published: April 1, 2020 Content info: 45 Pages
Description

The Global Pulmonary Arterial Hypertension Market is projected to reach USD 9,925.12 Million by 2025 from USD 7,196.48 Million in 2019, at a Compound Annual Growth Rate (CAGR) of 5.50%.

"The Prostacyclin & Prostacyclin Analog is projected to witness the highest growth during the forecast period"

On the basis of Drug Class, the Pulmonary Arterial Hypertension Market is studied across Calcium Channel Blocker, Endothelin Receptor Antagonists, Phosphodiesterase 5, and Prostacyclin & Prostacyclin Analog.

"The Online Pharmacy is projected to witness the highest growth during the forecast period"

On the basis of Distribution, the Pulmonary Arterial Hypertension Market is studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy.

Table of Contents
Product Code: MIR-47B0AE5

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Market Overview

  • 2.1. Introduction
  • 2.2. Pulmonary Arterial Hypertension Market, By Geography
  • 2.3. Pulmonary Arterial Hypertension Market, By Drug Class
  • 2.4. Pulmonary Arterial Hypertension Market, By Distribution

3. Pulmonary Arterial Hypertension Market, By Drug Class

  • 3.1. Introduction
  • 3.2. Calcium Channel Blocker
  • 3.3. Endothelin Receptor Antagonists
  • 3.4. Phosphodiesterase 5
  • 3.5. Prostacyclin & Prostacyclin Analog

4. Pulmonary Arterial Hypertension Market, By Distribution

  • 4.1. Introduction
  • 4.2. Hospital Pharmacy
  • 4.3. Online Pharmacy
  • 4.4. Retail Pharmacy

5. Appendix

  • 5.1. Discussion Guide
  • 5.2. Edition Details
  • 5.3. License Details
  • 5.4. Pricing Details

List of Figures

  • FIGURE 1. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, 2017-2025 (USD MILLION)
  • FIGURE 2. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  • FIGURE 3. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY DRUG CLASS, 2019 VS 2025 (USD MILLION)
  • FIGURE 4. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY DISTRIBUTION, 2019 VS 2025 (USD MILLION)
  • FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY DRUG CLASS, 2025 (USD MILLION)
  • FIGURE 6. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET, BY CALCIUM CHANNEL BLOCKER SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  • FIGURE 7. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET, BY ENDOTHELIN RECEPTOR ANTAGONISTS SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  • FIGURE 8. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET, BY PHOSPHODIESTERASE 5 SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  • FIGURE 9. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET, BY PROSTACYCLIN & PROSTACYCLIN ANALOG SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY DISTRIBUTION, 2025 (USD MILLION)
  • FIGURE 11. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET, BY HOSPITAL PHARMACY SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  • FIGURE 12. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET, BY ONLINE PHARMACY SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  • FIGURE 13. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET, BY RETAIL PHARMACY SIZE, BY GEOGRAPHY, 2019 (USD MILLION)

List of Tables

  • TABLE 1. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET: SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, 2017-2025 (USD MILLION)
  • TABLE 3. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
  • TABLE 4. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY CALCIUM CHANNEL BLOCKER, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 5. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY ENDOTHELIN RECEPTOR ANTAGONISTS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 6. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY PHOSPHODIESTERASE 5, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 7. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY PROSTACYCLIN & PROSTACYCLIN ANALOG, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 8. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY DISTRIBUTION, 2017-2025 (USD MILLION)
  • TABLE 9. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY HOSPITAL PHARMACY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 10. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY ONLINE PHARMACY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 11. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY RETAIL PHARMACY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 12. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET: EDITION DETAILS
  • TABLE 13. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET: LICENSE DETAILS
  • TABLE 14. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET: PRICING DETAILS
Back to Top